Transplanting stem cells to a diseased retina may be a method of treating certain common eye disorders in the future. In her dissertation, Lund scientist Anita Blixt Wojciechowski reports research findings that enhance the knowledge needed to make this treatment possible.
Retinitis pigmentosa is a hereditary retinal disease that affects one person in 3,500 and leads to severe vision impairment or blindness. Age-related deterioration of the yellow spot, the part of the retina that is most crucial to sharp vision, is another common cause of vision impairment. This disease (age related macular disease) affects nearly a third of all people over the age of 75. Today there is no good treatment for either disease.
Anita Blixt Wojciechowskis research involves transplanting fetal stem cells from rats to the eyes of adult rats. She has experienced both success and failure in her work.
Ingela Björck | alfa
Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University
Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
22.08.2017 | Health and Medicine
22.08.2017 | Materials Sciences
22.08.2017 | Life Sciences